company background image
AFX logo

Carl Zeiss Meditec XTRA:AFX Rapporto sulle azioni

Ultimo prezzo

€64.05

Cap. di mercato

€5.7b

7D

6.1%

1Y

-27.7%

Aggiornato

19 Aug, 2024

Dati

Dati finanziari dell'azienda +

Carl Zeiss Meditec AG

XTRA:AFX Rapporto sulle azioni

Cap. di mercato: €5.7b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

AFX Panoramica delle azioni

Carl Zeiss Meditec AG opera come azienda di tecnologia medica in Germania, nel resto d'Europa, in Nord America e in Asia.

AFX analisi fondamentale
Punteggio fiocco di neve
Valutazione4/6
Crescita futura2/6
Prestazioni passate2/6
Salute finanziaria5/6
Dividendi5/6

Carl Zeiss Meditec AG Concorrenti

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Carl Zeiss Meditec
Prezzi storici delle azioni
Prezzo attuale dell'azione€64.05
Massimo di 52 settimane€123.75
Minimo di 52 settimane€59.05
Beta0.95
1Variazione di 1 mese2.89%
Variazione a 3 mesi-31.09%
Variazione di 1 anno-27.71%
3Variazione a 3 anni-65.93%
Variazione a 5 anni-37.82%
Variazione dall'IPO83.00%

Notizie e aggiornamenti recenti

At €62.50, Is It Time To Put Carl Zeiss Meditec AG (ETR:AFX) On Your Watch List?

Aug 09
At €62.50, Is It Time To Put Carl Zeiss Meditec AG (ETR:AFX) On Your Watch List?

Carl Zeiss Meditec AG's (ETR:AFX) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Jul 11
Carl Zeiss Meditec AG's (ETR:AFX) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Recent updates

At €62.50, Is It Time To Put Carl Zeiss Meditec AG (ETR:AFX) On Your Watch List?

Aug 09
At €62.50, Is It Time To Put Carl Zeiss Meditec AG (ETR:AFX) On Your Watch List?

Carl Zeiss Meditec AG's (ETR:AFX) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Jul 11
Carl Zeiss Meditec AG's (ETR:AFX) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Stalled

Jun 10
Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Stalled

Carl Zeiss Meditec AG's (ETR:AFX) Popularity With Investors Is Under Threat From Overpricing

May 26
Carl Zeiss Meditec AG's (ETR:AFX) Popularity With Investors Is Under Threat From Overpricing

Carl Zeiss Meditec AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

May 11
Carl Zeiss Meditec AG Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

May 09
Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Is There Now An Opportunity In Carl Zeiss Meditec AG (ETR:AFX)?

Mar 24
Is There Now An Opportunity In Carl Zeiss Meditec AG (ETR:AFX)?

Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Mar 11
Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Slowing Rates Of Return At Carl Zeiss Meditec (ETR:AFX) Leave Little Room For Excitement

Feb 12
Slowing Rates Of Return At Carl Zeiss Meditec (ETR:AFX) Leave Little Room For Excitement

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Jan 29
Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

What Does Carl Zeiss Meditec AG's (ETR:AFX) Share Price Indicate?

Dec 08
What Does Carl Zeiss Meditec AG's (ETR:AFX) Share Price Indicate?

Carl Zeiss Meditec (ETR:AFX) Is Experiencing Growth In Returns On Capital

Nov 08
Carl Zeiss Meditec (ETR:AFX) Is Experiencing Growth In Returns On Capital

Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 37% Above Its Share Price

Oct 24
Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 37% Above Its Share Price

Is Carl Zeiss Meditec (ETR:AFX) A Risky Investment?

Sep 24
Is Carl Zeiss Meditec (ETR:AFX) A Risky Investment?

Should You Investigate Carl Zeiss Meditec AG (ETR:AFX) At €85.72?

Sep 08
Should You Investigate Carl Zeiss Meditec AG (ETR:AFX) At €85.72?

Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

Jul 24
Calculating The Fair Value Of Carl Zeiss Meditec AG (ETR:AFX)

We Like These Underlying Return On Capital Trends At Carl Zeiss Meditec (ETR:AFX)

Jun 19
We Like These Underlying Return On Capital Trends At Carl Zeiss Meditec (ETR:AFX)

Should You Think About Buying Carl Zeiss Meditec AG (ETR:AFX) Now?

Jun 06
Should You Think About Buying Carl Zeiss Meditec AG (ETR:AFX) Now?

Is Now The Time To Put Carl Zeiss Meditec (ETR:AFX) On Your Watchlist?

May 22
Is Now The Time To Put Carl Zeiss Meditec (ETR:AFX) On Your Watchlist?

Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 24% Below Its Share Price

Apr 19
Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 24% Below Its Share Price

Carl Zeiss Meditec (ETR:AFX) Has A Pretty Healthy Balance Sheet

Feb 26
Carl Zeiss Meditec (ETR:AFX) Has A Pretty Healthy Balance Sheet

Carl Zeiss Meditec's (ETR:AFX) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 10
Carl Zeiss Meditec's (ETR:AFX) Shareholders Will Receive A Bigger Dividend Than Last Year

Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching

Jan 28
Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching

Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

Jan 12
Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

Carl Zeiss Meditec (ETR:AFX) Will Pay A Larger Dividend Than Last Year At €1.10

Dec 29
Carl Zeiss Meditec (ETR:AFX) Will Pay A Larger Dividend Than Last Year At €1.10

Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

Dec 14
Carl Zeiss Meditec (ETR:AFX) Has Announced That It Will Be Increasing Its Dividend To €1.10

What Is Carl Zeiss Meditec AG's (ETR:AFX) Share Price Doing?

Nov 04
What Is Carl Zeiss Meditec AG's (ETR:AFX) Share Price Doing?

Calculating The Intrinsic Value Of Carl Zeiss Meditec AG (ETR:AFX)

Oct 18
Calculating The Intrinsic Value Of Carl Zeiss Meditec AG (ETR:AFX)

Investors Will Want Carl Zeiss Meditec's (ETR:AFX) Growth In ROCE To Persist

Sep 12
Investors Will Want Carl Zeiss Meditec's (ETR:AFX) Growth In ROCE To Persist

Carl Zeiss Meditec (ETR:AFX) Seems To Use Debt Rather Sparingly

Aug 25
Carl Zeiss Meditec (ETR:AFX) Seems To Use Debt Rather Sparingly

Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Hit The Brakes

May 30
Returns On Capital At Carl Zeiss Meditec (ETR:AFX) Have Hit The Brakes

Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Feb 27
Does Carl Zeiss Meditec (ETR:AFX) Have A Healthy Balance Sheet?

Carl Zeiss Meditec's (ETR:AFX) Returns Have Hit A Wall

Feb 08
Carl Zeiss Meditec's (ETR:AFX) Returns Have Hit A Wall

Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching

Dec 12
Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching

Carl Zeiss Meditec (ETR:AFX) Has Some Way To Go To Become A Multi-Bagger

Nov 06
Carl Zeiss Meditec (ETR:AFX) Has Some Way To Go To Become A Multi-Bagger

If You Like EPS Growth Then Check Out Carl Zeiss Meditec (ETR:AFX) Before It's Too Late

Sep 06
If You Like EPS Growth Then Check Out Carl Zeiss Meditec (ETR:AFX) Before It's Too Late

Investors Met With Slowing Returns on Capital At Carl Zeiss Meditec (ETR:AFX)

Aug 08
Investors Met With Slowing Returns on Capital At Carl Zeiss Meditec (ETR:AFX)

Here's Why We Think Carl Zeiss Meditec AG's (ETR:AFX) CEO Compensation Looks Fair for the time being

May 21
Here's Why We Think Carl Zeiss Meditec AG's (ETR:AFX) CEO Compensation Looks Fair for the time being

Why Carl Zeiss Meditec's (ETR:AFX) Shaky Earnings Are Just The Beginning Of Its Problems

May 18
Why Carl Zeiss Meditec's (ETR:AFX) Shaky Earnings Are Just The Beginning Of Its Problems

Capital Allocation Trends At Carl Zeiss Meditec (ETR:AFX) Aren't Ideal

Apr 28
Capital Allocation Trends At Carl Zeiss Meditec (ETR:AFX) Aren't Ideal

Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 19% Below Its Share Price

Mar 09
Carl Zeiss Meditec AG's (ETR:AFX) Intrinsic Value Is Potentially 19% Below Its Share Price

How Should Investors Feel About Carl Zeiss Meditec's (ETR:AFX) CEO Remuneration?

Feb 16
How Should Investors Feel About Carl Zeiss Meditec's (ETR:AFX) CEO Remuneration?

What Type Of Shareholders Own The Most Number of Carl Zeiss Meditec AG (ETR:AFX) Shares?

Jan 30
What Type Of Shareholders Own The Most Number of Carl Zeiss Meditec AG (ETR:AFX) Shares?

Rendimenti per gli azionisti

AFXDE Medical EquipmentDE Mercato
7D6.1%2.7%3.3%
1Y-27.7%7.5%4.7%

Ritorno vs Industria: AFX ha avuto una performance inferiore rispetto al German Medical Equipment che ha registrato un rendimento 7.5 % nell'ultimo anno.

Rendimento vs Mercato: AFX ha avuto una performance inferiore al mercato German che ha registrato un rendimento 4.7 % nell'ultimo anno.

Volatilità dei prezzi

Is AFX's price volatile compared to industry and market?
AFX volatility
AFX Average Weekly Movement7.1%
Medical Equipment Industry Average Movement4.2%
Market Average Movement4.9%
10% most volatile stocks in DE Market10.9%
10% least volatile stocks in DE Market2.6%

Prezzo delle azioni stabile: Il prezzo delle azioni di AFX è stato volatile negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 7% ) di AFX è rimasta stabile nell'ultimo anno, ma è comunque superiore al 75% delle azioni German.

Informazioni sull'azienda

FondatoI dipendentiAMMINISTRATORE DELEGATOSito web
18464,950Markus Weberwww.zeiss.com/meditec-ag/de/investor-relations.html?vaURL=www.zeiss.de/meditec-ag/ir

Carl Zeiss Meditec AG opera come società di tecnologia medica in Germania, nel resto d'Europa, in Nord America e in Asia. Opera in due segmenti, Oftalmologia e Microchirurgia. Il segmento Oftalmologia offre prodotti e soluzioni per la diagnosi e il trattamento di patologie oculari croniche, quali ametropia (refrazione), cataratta, glaucoma e disturbi renali.

Carl Zeiss Meditec AG Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Carl Zeiss Meditec con la sua capitalizzazione di mercato?
AFX statistiche fondamentali
Capitalizzazione di mercato€5.73b
Guadagni(TTM)€203.20m
Ricavi(TTM)€2.07b

28.2x

Rapporto P/E

2.8x

Rapporto P/S

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
AFX Conto economico (TTM)
Ricavi€2.07b
Costo del fatturato€927.44m
Profitto lordo€1.14b
Altre spese€935.57m
Guadagni€203.20m

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

Dec 11, 2024

Utile per azione (EPS)2.27
Margine lordo55.11%
Margine di profitto netto9.83%
Rapporto debito/patrimonio netto6.7%

Come si è comportato AFX nel lungo periodo?

Vedi performance storica e confronto

Dividendi

1.7%

Rendimento attuale del dividendo

38%

Rapporto di remunerazione